IL-4/IL-13 trap (Regeneron)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIL-4/IL-13 trap (Regeneron)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionInterleukin-4 receptors inhibitorsInterleukin 13 receptor inhibitors
TargetsInterleukin 13 receptorInterleukin-4 receptors
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A